Inogen | INGN - Cost Of Sales


Inogen reported $39.59M in Cost of Sales for its fiscal quarter ending in September of 2024.





Cost Of Sales Change Date
Abbott USD 5.94B 642M Jun/2026
Accuray USD 116.17M 14.63M Dec/2024
AngioDynamics USD 37.29M 786K Sep/2025
Artivion USD 42.85M 3.86M Dec/2025
AtriCure USD 34.98M 3.04M Jun/2026
Baxter International USD 1.93B 118M Jun/2026
Becton, Dickinson and Co. USD 2.67B 108M Jun/2026
Boston Scientific USD 1.86B 29M Jun/2026
Cooper Companies USD 393.8M 17M Mar/2026
Dexcom USD 478.4M 36.8M Jun/2026
Edwards Lifesciences USD 392.4M 29.8M Jun/2026
Globus Medical USD 271M 7.41M Jun/2026
Inogen USD 39.59M 1.27M Sep/2024
Insulet USD 239.1M 6.4M Jun/2026
Medtronic USD 3.8B 195M Mar/2026
Orthofix International USD 66.63M 6.4M Dec/2025
Philips EUR 2.21B 70M Jun/2026
ResMed USD 612.93M 61.26M Jun/2026
Steris USD 808.6M 82.7M Jun/2026
Stryker USD 2.26B 106M Jun/2026
Tandem Diabetes Care USD 109.78M 653K Jun/2026
Teleflex USD 238.62M 2.21M Jun/2026
X T L Biopharmaceuticals USD 332K 216K Dec/2024
Zimmer Biomet Holdings USD 815.9M 77.6M Jun/2026